Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Regular treatment of asthma Age: Adult Condition: Initial treatment |
Dose: Inhalation – 2 puffs of 100 mcg/5 mcg Frequency: twice daily Note: May increase to higher dose after 2 weeks if inadequate response. Indicated where use of a combination (Long-acting beta2-agonist + Inhaled Corticosteroid) has been found to be appropriate. Maximum daily dose: 800 mcg/20 mcg daily. |
|
Indication: Regular treatment of asthma Age: Adult Condition: Severe asthma (initial) or inadequate response to lower dose after 2 weeks |
Dose: Inhalation – 2 puffs of 200 mcg/5 mcg Frequency: twice daily Note: Maximum daily dose: 800 mcg/20 mcg daily. Indicated where use of a combination (Long-acting beta2-agonist + Inhaled Corticosteroid) has been found to be appropriate. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: greater than 12 years |
Dose: 2 puffs of 100 mcg/5 mcg inhaled Frequency: twice daily Note: initial dose; may increase to higher dose after 2 weeks if inadequate response; maximum daily dose: 800 mcg/20 mcg daily |
|
Age: greater than 12 years Condition: Severe asthma (initial) |
Dose: 2 puffs of 200 mcg/5 mcg inhaled Frequency: twice daily Note: maximum daily dose: 800 mcg/20 mcg daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not specified Note: There are no data regarding the specific use of this combination in patients with renal impairment. |
Administration
- Shake well before each use
- Rinse mouth after use
Side Effect
- Nasopharyngitis (4.7%)
- Headache (2-4.5%)
- Sinusitis (2-3.3%)
- Oral candidiasis
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir, cobicistat-containing products)
|
Increased plasma concentration of mometasone
|
|
Xanthine Derivatives (Theophylline, Aminophylline, Caffeine), non-potassium sparing diuretics
|
Enhanced hypokalaemic effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Status Asthmaticus
|
Not suitable for emergency treatment
|
|
Exercise-Induced Bronchospasm
|
Not indicated for immediate relief
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep out of the reach of children. Store below 30°C protected from direct sunlight and heat. Keep away from contact of eyes. The container should not be punctured, broken or burnt even when apparently empty.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.